help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2008-0710
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kazlauskaite, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kazlauskaite, R.
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Neuroendocrinology and Pituitary
The Journal of Clinical Endocrinology & Metabolism Vol. 93, No. 11 4245-4253
Copyright © 2008 by The Endocrine Society

Corticotropin Tests for Hypothalamic-Pituitary- Adrenal Insufficiency: A Metaanalysis

Rasa Kazlauskaite, Arthur T. Evans, Carmen V. Villabona, Tariq A. M. Abdu, Bruno Ambrosi, A. Brew Atkinson, Cheung Hei Choi, Richard N. Clayton, C. Hamish Courtney, E. Nazli Gonc, Mohamad Maghnie, Susan R. Rose, Steven G. Soule, Karen Tordjman Consortium for Evaluation of Corticotropin Test in Hypothalamic-Pituitary Adrenal Insufficiency

John H. Stroger Jr. Hospital of Cook County and Rush Medical College (R.K., A.T.E., C.V.V.), Chicago, Illinois 60612; Walsall Manor Hospital National Health Service Trust (T.A.M.A.), Walsall, WS2 9PS United Kingdom; University of Milan and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Donato (B.A.), San Donato Milanese 20097, Italy; Regional Centre for Endocrinology and Diabetes (A.B.A., C.H.C.), Royal Victoria Hospital, Belfast BT12 6BA, United Kingdom; Queen Elizabeth Hospital (C.H.C.), Hong Kong Special Administrative Region; Keele University and North Staffordshire Hospital (R.N.C.), Stoke-on-Trent ST4 7QB,United Kingdom; Hacettepe University (E.N.G.), 06100 Ankara, Turkey; IRCCS G. Gaslini (M.M.), University of Genova, 5-16147 Genova, Italy; Cincinnati Children’s Hospital Medical Center and University of Cincinnati (S.R.R.), Cincinnati, Ohio 45229; Christchurch Hospital (S.G.S.), Christchurch, New Zealand; and Institute of Endocrinology, Metabolism, and Hypertension (K.T.), Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel

Address all correspondence and requests for reprints to: Rasa Kazlauskaite, M.D., M.Sc., 1900 West Polk Street, Room 806, Chicago, Illinois 60612. E-mail: rasa_kazlauskaite{at}rush.edu.

Context: The diagnostic value of tests for detecting hypothalamic-pituitary adrenal insufficiency (HPAI) is controversial.

Objective: Our objective was to compare standard-dose and low-dose corticotropin tests for diagnosing HPAI.

Data Sources: We searched the PubMed database from 1966–2006 for studies reporting diagnostic value of standard-dose or low-dose corticotropin tests, with patient-level data obtained from original investigators.

Study Selection: Eligible studies had more than 10 patients. All subjects were evaluated because of suspicion for chronic HPAI, and patient-level data were available. We excluded studies with no accepted reference standard for HPAI (insulin hypoglycemia or metyrapone test) if test subjects were in the intensive care unit or if only normal healthy subjects were used as controls.

Data Extraction: We constructed receiver operator characteristic (ROC) curves using patient-level data from each study and then merged results to create summary ROC curves, adjusting for study size and cortisol assay method. Diagnostic value of tests was measured by calculating area under the ROC curve (AUC) and likelihood ratios.

Data Synthesis: Patient-level data from 13 of 23 studies (57%; 679 subjects) were included in the metaanalysis. The AUC were as follows: low-dose corticotropin test, 0.92 (95% confidence interval 0.89–0.94), and standard-dose corticotropin test, 0.79 (95% confidence interval 0.74–0.84). Among patients with paired data (seven studies, 254 subjects), diagnostic value of low-dose corticotropin test was superior to standard-dose test (AUC 0.94 and 0.85, respectively; P < 0.001).

Conclusions: Low-dose corticotropin test was superior to standard-dose test for diagnosing chronic HPAI, although it has technical limitations.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
A. Fernandez, M. Brada, L. Zabuliene, N. Karavitaki, and J. A H Wass
Radiation-induced hypopituitarism
Endocr. Relat. Cancer, September 1, 2009; 16(3): 733 - 772.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. A. Kaufman, L. Seravalli, E. Anton, and S. R. Bornstein
Predisposing Factors for Adrenal Insufficiency
N. Engl. J. Med., August 20, 2009; 361(8): 824 - 825.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society